Why is "Alopecia areata" trending?
Latest news, Wikipedia summary, and trend analysis.
Trend Analysis
- Ranking position: #
- Date: 2026-03-21 03:59:01
This topic has appeared in the trending rankings 1 time(s) in the past year. While it does not trend frequently, its appearance suggests a renewed or concentrated surge of public interest.
Based on Wikipedia pageviews and search interest, this topic gained significant attention on the selected date.
Trend Insight
Alopecia_areata entered the ranking for the first time today at position #. This is its highest position ever recorded.
Trend History
This topic has appeared in the English Wikipedia rankings 1 time. It first appeared on 2026-03-21 and was most recently seen on 2026-03-21.
Wikipedia Overview
Alopecia areata (AA), also known as spot baldness, is a condition in which hair is lost from some or all areas of the body. It often results in a few bald spots on the scalp, each about the size of a coin. Psychological stress and illness are possible factors in bringing on alopecia areata in individuals at risk, but in most cases there is no obvious trigger. People are generally otherwise healthy. In a few cases, all the hair on the scalp is lost, or all body hair is lost. Hair loss can be permanent or temporary.
Read more on Wikipedia →Related Topics
Trending Topic Today
Search Interest Perspective
-
Treating Psoriasis and Alopecia Areata Beyond the Skin: An Integrative Approach - Dermatology Times
-
Efficacy and Safety of JAK Inhibitors for Alopecia Areata - Docwire News
-
Consensus Algorithm Pairs Alopecia Areata Severity With Quality of Life Impact - The American Journal of Managed Care
-
Arthritis drug restores 100% hair on 1 in 5 alopecia patients in global trial - South China Morning Post
-
Q&A: Upadacitinib's Safety Profile and Role in Severe Alopecia Areata Care - HCPLive
-
Alopecia Areata Awareness Month: local NAAF chapter aims to raise $50,000 for research - WJLA
-
What to Know About Europe’s New Alopecia Areata Pill - NewBeauty
-
WWE’s Thea Hail Confirms Alopecia Areata Diagnosis, Shares New Look - Yahoo Sports
-
Alopecia areata: Rheumatoid arthritis drug may treat hair loss - Medical News Today
-
Drug used for arthritis shows promise against severe hair loss - Interesting Engineering
-
Rheumatoid arthritis drug also may help people with hair loss caused by severe alopecia - PhillyVoice
-
Can We Add Upadacitinib to the Alopecia Areata Arsenal? - Docwire News
-
Syracuse 'Walk for Alopecia' coming up, one volunteer is doing it for her daughter - WSTM
-
Upadacitinib Effective for Severe Alopecia Areata - Medscape
-
Upadacitinib for Severe Alopecia Areata - Physician's Weekly
-
Q&A: Translating UP-AA Trial Data Into Real-World Alopecia Areata Outcomes - HCPLive
-
Closing Evidence Gaps in Managed Care for Pediatric Alopecia Areata: A Q&A With Brittany Craiglow, MD - The American Journal of Managed Care
-
Q&A: Upadacitinib Meets Primary Endpoint in Severe Alopecia Areata Trials - HCPLive
-
JAK Inhibitor Hesitancy and Step Therapy in Pediatric Alopecia Areata: A Q&A With Brittany Craiglow, MD - The American Journal of Managed Care
-
Upadacitinib: Clinical Trial Results for Alopecia Areata - HCPLive
-
Common prescription drug delivers surprising results in hair-loss study - Cleveland.com
-
Thea Hail Reveals She Has Alopecia Areata - Fightful
-
Expanding Oral JAK Inhibitor Options for Children With AD and Alopecia Areata - Dermatology Times
-
Hair Regrowth: New Data on Upadacitinib for Severe Alopecia Areata - HCPLive
-
4 perspectives on the life-changing power of the Walk For Alopecia - The Ridgecrest Daily Independent
-
4 perspectives on the life-changing power of the Walk For Alopecia - KPVI
-
JAK Inhibitor Might Be the Most Effective One Yet for Severe Alopecia - MedPage Today
-
IL-15 in alopecia areata: the immune tolerance mechanistic insights and translational perspectives - Frontiers
-
Alopecia: Common Arthritis Drug Shows Promise for Hair Regrowth - Healthline
-
Myth Buster: Alopecia Areata Awareness has Solved the Stigma Problem - HMP Global Learning Network
-
Arthritis Drug Can Regrow Up to 80 Percent of Hair - Yahoo Life UK
-
JAK Inhibitors Reshaped Alopecia Areata Care, but Long-Term Data Gaps Remain - The American Journal of Managed Care
-
Topline Results: Bempikibart Shows Promise in Phase 2a Part B Alopecia Areata Trial - The Dermatology Digest
-
Arthritis Drug Shows Strong Hair Regrowth Results in Alopecia Areata Trials - EURweb
-
9 Self-Care Tips for Managing Alopecia Areata - Health.com
-
A Dermatologist Explains Alopecia Areata: When Genetics and Stress Trigger Alopecia - Black Doctor
-
Bempikibart Shows Positive Phase 2a Results in Alopecia Areata - Dermatology Times
-
Beyond the SALT Score: Evaluating Alopecia Areata More Holistically - The American Journal of Managed Care
-
Alopecia Areata Takes a Hidden Toll on Work, Relationships, and Self-Care - The American Journal of Managed Care
-
Q&A: New FDA Filing Signals Potential Shift in Severe Alopecia Areata Treatment - Physician's Weekly
-
SIGNAL-AA: Bempikibart Effective for Alopecia Areata at 36 Weeks - HCPLive
-
Three Years on Baricitinib Preserved Hair Regrowth in Severe Alopecia Areata - The American Journal of Managed Care
-
Upadacitinib Receives Positive CHMP Opinion for Severe Alopecia Areata - Dermatology Times
-
An Immunophenotype-Guided Approach to Overlapping AD and Alopecia Areata - The American Journal of Managed Care
-
Improving Alopecia Areata Outcomes Using JAK Inhibitors - Medscape Reference: Drugs, Diseases & Medical Procedures
-
Myth Buster: Alopecia Areata is Just Hair Loss - HMP Global Learning Network
-
JAK Inhibitors Reshape Alopecia Areata Care, Spanish Experts Say in New Consensus - The American Journal of Managed Care
-
Beyond JAK Inhibitors: Biologics Signal a New Era in Alopecia Areata - Pharmaceutical Executive
-
Janus Kinase Inhibitors for Alopecia Areata Have Distinct Safety Profiles - Dermatology Advisor
-
Upadacitinib hair regrowth trial findings in severe alopecia areata - Pharmacy Business
-
Real-World Analysis Supports Ritlecitinib Use in Adolescents With Severe Alopecia Areata - The American Journal of Managed Care
-
Managing the Burden of Severe Alopecia Areata in Adults - Medscape Reference: Drugs, Diseases & Medical Procedures
-
WWE Star Thea Hail Reveals Sad Reason For Drastic 2026 Hair Change - Sportsnaut
-
EU first to clear AbbVie's Rinvoq for alopecia areata - pharmaphorum
-
Improving Treatment Satisfaction in Alopecia Areata - Medscape Reference: Drugs, Diseases & Medical Procedures
-
Upadacitinib Effective for Severe Alopecia Areata in phase 3 trial - Medical Dialogues
-
Identification and Treatment of Severe Alopecia Areata - Medscape Reference: Drugs, Diseases & Medical Procedures
-
S3 guideline diagnostics and therapy in alopecia areata – Part 2: Therapy, psychosocial and cosmetic support - Wiley Online Library
-
What Upadacitinib Could Mean for Younger Patients With Severe Alopecia Areata - HCPLive
-
Want to stop losing your hair from alopecia areata? Here’s what to try - Health.com
-
Q32 Bio reports 36-week data from SIGNAL-AA trial’s Part B in alopecia areata - Clinical Trials Arena
-
Deuruxolitinib in Alopecia Areata: Trial Data, Onset of Action, and Adverse Event Management - The American Journal of Managed Care
-
Comparing the Clinical Trials of Baricitinib and Ritlecitinib in Alopecia Areata - The American Journal of Managed Care
-
Common arthritis pill repurposed to boost hair regrowth in alopecia patients - Medical Xpress
-
JAK Inhibitors in Alopecia Areata: Clinical Rationale and FDA-Approved Therapies - The American Journal of Managed Care
-
Drugmaker Seeks Alopecia Areata Indication for Upadacitinib - Medscape
-
Upadacitinib sNDA Submitted to FDA for Severe Alopecia Areata - HCPLive
-
Do Your Nails Look or Feel Different? Could It Be From Alopecia? - Health.com
-
Recognizing Alopecia Areata: Pathophysiology, Medical Impact, and Epidemiological Trends - The American Journal of Managed Care
-
Understanding Alopecia Areata: Terminology, Misconceptions, and Patient Education - HCPLive
-
Deuruxolitinib Demonstrates Consistent Efficacy, Early Hair Regrowth in Severe Alopecia Areata - The American Journal of Managed Care
-
A Rare Triad of Alopecia Areata, Morphea, and Psoriasis in a Patient - Ovid
-
REZOLVE-AA: 52-Week Data Highlight Positive Alopecia Areata Outcomes with Rezpegaldesleukin - HCPLive
-
From Specialist Roles to Unmet Needs: Advancing Alopecia Areata Care - The American Journal of Managed Care
-
Dental Rehabilitation of a Child Diagnosed With Alopecia Areata Totalis: A Case Report - Cureus
-
Case Report: Dupilumab induced sustained complete remission in a child with severe alopecia areata and markedly elevated IgE - Frontiers
-
AbbVie seeks FDA approval for upadacitinib in severe alopecia areata - Contemporary Pediatrics
-
Beyond hair loss: New Chinese guidelines put patient psychology and JAK inhibitors at the center of alopecia areata care - EurekAlert!
-
Myth Buster: Alopecia Areata is Caused by Nutritional Deficiencies - HMP Global Learning Network
-
52-Week Topline Results from 16-Week Blinded Treatment Extension of REZOLVE-AA Demonstrate Deepening of Responses in Severe-to-Very-Severe Alopecia Areata with Rezpegaldesleukin - PR Newswire
-
Review Findings Question the Assumed Skin Cancer Risks in Alopecia Areata - The American Journal of Managed Care
-
HCW9302, HCW Biologics’ IL-2Rα-Biased Fusion Immunotherapeutic, Shows Preliminary Clinical Activity in Phase 1 Alopecia Areata Trial with Favorable Early Safety Profile - BioPharm International
-
Successful treatment of extensive ritlecitinib-refractory alopecia are | CCID - Dove Medical Press
-
Myth Buster: JAK Inhibitors Cure Alopecia Areata - HMP Global Learning Network
-
Topical Immunotherapy Remains Valuable in Alopecia Areata - The American Journal of Managed Care
-
Q32’s stock jumps 60% on latest phase 2 alopecia data for potential rival to JAK inhibitors - Fierce Biotech
-
Misan University’s Master's Thesis on Designing Novel Topical Nano-System for Treating Alopecia Areata - وزارة التعليم العالي والبحث العلمي
-
Myth Buster: If Your Hair Grows Back, Alopecia Areata is Gone - HMP Global Learning Network
-
Psychological Aspects of Alopecia Areata Need Focus in the Future: Maria Hordinsky, MD - The American Journal of Managed Care
-
Air Pollution Exposure Linked to Increased Risk of Alopecia Areata - EMJ
-
Success of Deuruxolitinib (Leqselvi™) in Extensively Treatment-Resistant Alopecia Universalis: A Case Report - Cureus
-
Immune Overlap Between AA and AD Fuels New Treatment Approaches - The American Journal of Managed Care
-
Q32 Bio Announces Positive 36-Week Topline Results from Part B of the SIGNAL-AA Clinical Trial of Bempikibart in Alopecia Areata - Yahoo Finance
-
Rethinking Severity Assessment in Alopecia Areata - Dermatology Times
-
S3 guideline diagnostics and therapy of alopecia areata – Part 1: Diagnostics and epidemiology - Wiley Online Library
-
New data highlight benefits of rezpegaldesleukin for severe alopecia areata - Healio
-
Q32 Bio reports top-line results for bempikibart in alopecia areata - The Pharma Letter
-
First in Class Rezpegaldesleukin: Favorable Safety, Durable Responses in Alopecia Areata, With David Rosmarin, MD - HCPLive
-
Risk for alopecia areata development in atopic dermatitis falls after starting dupilumab - Healio
-
Q32 Bio Secures $55 Million Private Placement to Advance Alopecia Areata Pipeline (QTTB) - Yahoo Finance
Why This Topic Is Trending
This topic has recently gained attention due to increased public interest. Search activity and Wikipedia pageviews suggest growing global engagement.
Search Interest & Related Topics
Search interest data over the past 12 months indicates that this topic periodically attracts global attention. Sudden spikes often correlate with major news events, public statements, or geopolitical developments.